Recent News

• 04.14.2025 - MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025
• 04.14.2025 - MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025
• 04.14.2025 - MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025
• 04.08.2025 - First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients
• 04.08.2025 - First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients
• 04.08.2025 - First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients
• 12.05.2024 - MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND
• 12.05.2024 - MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND
• 12.05.2024 - MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND
• 11.19.2024 - MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders

Recent Filings

• 03.11.2025 - 8-K Current report
• 03.11.2025 - EX-99.1 EX-99.1
• 02.19.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.10.2025 - 4 Statement of changes in beneficial ownership of securities